Related Experiment Video
Updated: Aug 8, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Amino acid analogs IV:4-fluoroisoleucine
Abstract:
4-Fluoroisoleucine was produced by ammonolysis of 2-bromo-4-fluoro-3-methylpentanoic acid, which resulted from the bromofluorination of 4-methyl-2-pentenoic acid. It did not inhibit Plasmodium berghei in mice at 640 mg/kg and was not toxic to the animals. The fluoroamino acid inhibited Aspergillus niger, Trichoderma viride, Myrothecium verrucaria, Trichophyton mentagrophytes, and Mucor mucedo in Czapek solution agar at a concentration between 10(4) and 10(3) microgram/ml. Growth of Escherichia coli was inhibited 25% at 900 microgram/ml in a defined medium.
Insights
4-Fluoroisoleucine, a novel fluoroamino acid, demonstrated antifungal activity against several fungal species but showed no efficacy against Plasmodium berghei in mice. This compound was well-tolerated in animal models, indicating potential for further investigation.
Area of Science:
- Biochemistry
- Organic Chemistry
- Medicinal Chemistry
Background:
- Fluorinated amino acids are recognized for their diverse biological activities.
- Investigating novel amino acid derivatives is crucial for discovering new therapeutic agents.
Purpose of the Study:
- To synthesize and evaluate the biological activity of 4-Fluoroisoleucine.
- To assess the antifungal and antimalarial potential of 4-Fluoroisoleucine.
- To determine the toxicity profile of 4-Fluoroisoleucine in vivo.
Main Methods:
- Synthesis of 4-Fluoroisoleucine via ammonolysis of a bromofluorinated precursor.
- Antifungal screening against Aspergillus niger, Trichoderma viride, Myrothecium verrucaria, Trichophyton mentagrophytes, and Mucor mucedo.
- In vivo antimalarial assay using Plasmodium berghei in mice.
- Bacterial growth inhibition assay with Escherichia coli.
Main Results:
- 4-Fluoroisoleucine exhibited antifungal activity against a range of fungi at concentrations between 10^3 and 10^4 µg/ml.
- No significant inhibition of Plasmodium berghei was observed at 640 mg/kg.
- No toxicity was noted in mice at the tested dosage.
- 25% inhibition of Escherichia coli growth was observed at 900 µg/ml.
Conclusions:
- 4-Fluoroisoleucine possesses notable antifungal properties.
- The compound lacks antimalarial activity and demonstrates a favorable safety profile in mice.
- Further research into 4-Fluoroisoleucine's antifungal mechanisms and potential applications is warranted.
More Related Videos
10:31Residue-Specific Exchange of Proline by Proline Analogs in Fluorescent Proteins: How "Molecular Surgery" of the Backbone Affects Folding and Stability
Published on: February 3, 2022
10:24A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Related Concept Videos
DNA Base Pairing
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Dipeptidyl Peptidase 4 Inhibitors
Amino Acid Biosynthetic Pathways
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Viral Protein Synthesis